180 Wealth Advisors, LLC Tekla Life Sciences Investors Transaction History

180 Wealth Advisors, LLC

$629 Million
Q3 2024

A detailed history of 180 Wealth Advisors, LLC transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, 180 Wealth Advisors, LLC holds 134,166 shares of HQL stock, worth $1.85 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

134,166

Previous 136,231 1.52%

Holding current value

$1.85 Million

Previous $1.93 Million 4.82%

% of portfolio

0.32%

Previous 0.33%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$14.26 - $15.78 $29,446 - $32,585	-2,065 Reduced 1.52%	134,166 $2.02 Million
Q2 2024 Jul 16, 2024	BUY	$12.79 - $14.27 $47,092 - $52,542	3,682 Added 2.78%	136,231 $1.93 Million
Q1 2024 Apr 15, 2024	BUY	$13.38 - $14.33 $127,832 - $136,908	9,554 Added 7.77%	132,549 $1.81 Million
Q4 2023 Jan 24, 2024	BUY	$11.35 - $13.6 $93,875 - $112,485	8,271 Added 7.21%	122,995 $1.66 Million
Q3 2023 Oct 31, 2023	BUY	$12.38 - $13.69 $70,875 - $78,375	5,725 Added 5.25%	114,724 $1.43 Million
Q2 2023 Jul 11, 2023	SELL	$13.13 - $14.17 $37,512 - $40,483	-2,857 Reduced 2.55%	108,999 $1.48 Million
Q1 2023 Apr 07, 2023	BUY	$13.37 - $14.94 $32,061 - $35,826	2,398 Added 2.19%	111,856 $1.56 Million
Q4 2022 Feb 02, 2023	BUY	$13.55 - $15.23 $83,007 - $93,298	6,126 Added 5.93%	109,458 $1.56 Million
Q3 2022 Oct 12, 2022	BUY	$13.39 - $16.31 $111,685 - $136,041	8,341 Added 8.78%	103,332 $1.41 Million
Q2 2022 Jul 11, 2022	BUY	$13.11 - $17.02 $129,880 - $168,617	9,907 Added 11.64%	94,991 $1.38 Million
Q1 2022 Apr 22, 2022	BUY	$15.35 - $19.29 $254,103 - $319,326	16,554 Added 24.16%	85,084 $1.43 Million
Q4 2021 Jan 26, 2022	BUY	$18.5 - $21.59 $100,418 - $117,190	5,428 Added 8.6%	68,530 $1.19 Million
Q3 2021 Oct 28, 2021	SELL	$20.27 - $22.67 $9,526 - $10,654	-470 Reduced 0.74%	63,102 $1.3 Million
Q2 2021 Aug 13, 2021	SELL	$19.14 - $21.44 $3,694 - $4,137	-193 Reduced 0.3%	63,572 $1.38 Million
Q1 2021 May 25, 2021	BUY	$19.31 - $22.07 $122,792 - $140,343	6,359 Added 11.08%	63,765 $1.26 Million
Q4 2020 Jan 27, 2021	BUY	$16.8 - $20.21 $4,720 - $5,679	281 Added 0.49%	57,406 $1.19 Million
Q3 2020 Oct 23, 2020	SELL	$16.71 - $19.06 $15,757 - $17,973	-943 Reduced 1.62%	57,125 $1.01 Million
Q2 2020 Jul 21, 2020	SELL	$14.22 - $18.38 $83,044 - $107,339	-5,840 Reduced 9.14%	58,068 $1.1 Million
Q1 2020 Apr 09, 2020	BUY	$12.22 - $17.99 $59,755 - $87,971	4,890 Added 8.29%	63,908 $938,000
Q4 2019 Jan 17, 2020	BUY	$14.63 - $17.84 $109,827 - $133,924	7,507 Added 14.57%	59,018 $1.05 Million
Q3 2019 Oct 22, 2019	BUY	$15.09 - $17.09 $164,797 - $186,639	10,921 Added 26.91%	51,511 $766,000
Q2 2019 Aug 05, 2019	BUY	$15.54 - $17.47 $80,497 - $90,494	5,180 Added 14.63%	40,590 $664,000
Q1 2019 May 14, 2019	BUY	$15.5 - $17.9 $548,855 - $633,839	35,410 New	35,410 $581,000

Others Institutions Holding HQL

# of Institutions

Shares Held

9.31M

Call Options Held

Put Options Held

View Full List

About TEKLA LIFE SCIENCES INVESTORS

Ticker HQL
Exchange NYSE
Sector Financial Services
Industry Asset Management
Description
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...

More about HQL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of 180 Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 180 Wealth Advisors, LLC with notifications on news.

Account

180 Wealth Advisors, LLC Tekla Life Sciences Investors Transaction History